|
|
???tair.name??? >
???browser.page.title.author???
|
"chun jen liu"???jsp.browse.items-by-author.description???
Showing items 331-355 of 543 (22 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-01-24T09:30:55Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators |
| 臺大學術典藏 |
2022-01-24T09:30:55Z |
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
|
Cheng P.-N.; Chen C.-Y.; Yu M.-L.; Lin C.-C.; Lin C.-Y.; Peng C.-Y.; Tseng K.-C.; Lo C.-C.; Tseng I.-H.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:30:55Z |
Molecular mechanisms and animal models of HBV-related hepatocellular carcinoma: With emphasis on metastatic tumor antigen 1
|
Li Y.-T.; Wu H.-L.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:30:54Z |
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
|
Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
| 臺大學術典藏 |
2022-01-24T09:30:54Z |
Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan
|
Lee W.-C.; Chen T.-K.; Han H.-F.; Lin Y.-C.; Hwang Y.-M.; Kao J.-H.; Chen P.-J.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:30:53Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; CHUN-JEN LIU; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:30:53Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:52Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; CHUN-JEN LIU; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:52Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Lin C.-L.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; CHUN-JEN LIU; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Kao J.-H.; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:30:52Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
Hong C.-M.; Lin Y.-Y.; CHUN-JEN LIU; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; Kao J.-H.; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J. |
| 臺大學術典藏 |
2022-01-24T09:30:51Z |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng P.-N.; CHUN-JEN LIU; Chen C.-Y.; Tseng K.-C.; Lo C.-C.; Peng C.-Y.; Lin C.-L.; Chiu H.-C.; Chiu Y.-C.; Chen P.-J. |
| 臺大學術典藏 |
2022-01-15T00:07:58Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang, Chung Feng; Kuo, Hsing Tao; Chang, Te Sheng; Lo, Ching Chu; Hung, Chao Hung; Huang, Chien Wei; Chong, Lee Won; Cheng, Pin Nan; Yeh, Ming Lun; Peng, Cheng Yuan; Cheng, Chien Yu; Huang, Jee Fu; Bair, Ming Jong; Lin, Chih Lang; Yang, Chi Chieh; Wang, Szu Jen; Hsieh, Tsai Yuan; Lee, Tzong Hsi; Lee, Pei Lun; Wu, Wen Chih; Lin, Chih Lin; Su, Wei Wen; Yang, Sheng Shun; CHIA-CHI WANG; Hu, Jui Ting; Mo, Lein Ray; CHUN-TING CHEN; Huang, Yi Hsiang; Chang, Chun Chao; Huang, Chia Sheng; Chen, Guei Ying; Kao, Chien Neng; Tai, Chi Ming; CHUN-JEN LIU; Lee, Mei Hsuan; Tsai, Pei Chien; Dai, Chia Yen; JIA-HORNG KAO; Lin, Han Chieh; Chuang, Wang Long; Chen, Chi Yi; Tseng, Kuo Chih; Yu, Ming Lung |
| 臺大學術典藏 |
2022-01-15T00:07:58Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, Pin Nan; Mo, Lein Ray; CHUN-TING CHEN; Chen, Chi Yi; Huang, Chung Feng; Kuo, Hsing Tao; Lo, Ching Chu; Tseng, Kuo Chih; Huang, Yi Hsiang; Tai, Chi Ming; Peng, Cheng Yuan; Bair, Ming Jong; CHIEN-HUNG CHEN; Yeh, Ming Lun; Lin, Chih Lang; Lin, Chun Yen; Lee, Pei Lun; Chong, Lee Won; Hung, Chao Hung; Chang, Te Sheng; Huang, Jee Fu; Yang, Chi Chieh; Hu, Jui Ting; Lin, Chih Wen; CHIA-CHI WANG; Su, Wei Wen; Hsieh, Tsai Yuan; Lin, Chih Lin; Tsai, Wei Lun; Lee, Tzong Hsi; Chen, Guei Ying; Wang, Szu Jen; Chang, Chun Chao; Yang, Sheng Shun; Wu, Wen Chih; Huang, Chia Sheng; Chou, Kwok Hsiung; Kao, Chien Neng; Tsai, Pei Chien; CHEN-HUA LIU; Lee, Mei Hsuan; Cheng, Chien Yu; Tsai, Ming Chang; CHUN-JEN LIU; Dai, Chia Yen; Lin, Han Chieh; JIA-HORNG KAO; Chuang, Wan Long; Yu, Ming Lung |
| 臺大學術典藏 |
2022-01-15T00:07:46Z |
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study
|
Papatheodoridi, Margarita; TUNG-HUNG SU; Hadziyannis, Emilia; Liao, Chun Hsun; Orfanidou, Αfroditi; Yang, Hung Chi; Zachou, Kalliopi; CHUN-JEN LIU; Kourikou, Anastasia; Gatselis, Nikolaos; Manolakopoulos, Spilios; Dalekos, George; JIA-HORNG KAO; Hadziyannis, Stephanos; Papatheodoridis, George V. |
| 臺大學術典藏 |
2021-12-14T23:12:17Z |
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors
|
MING-WHEI YU; Lin, Chih Lin; CHUN-JEN LIU; YI-WEN HUANG; Hu, Jui Ting; Wu, Wan Jung; Wu, Chih Feng |
| 臺大學術典藏 |
2021-12-14T23:12:16Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang, Chung Feng; Tseng, Kuo Chih; Cheng, Pin Nan; Hung, Chao Hung; Lo, Ching Chu; Peng, Cheng Yuan; Bair, Ming Jong; Yeh, Ming Lun; CHIEN-HUNG CHEN; Lee, Pei Lun; Lin, Chun Yen; Kuo, Hsing Tao; CHUN-TING CHEN; Yang, Chi Chieh; Huang, Jee Fu; Tai, Chi Ming; Hu, Jui Ting; Lin, Chih Lang; Su, Wei Wen; Tsai, Wei Lun; Huang, Yi Hsiang; Cheng, Chien Yu; Lin, Chih Lin; CHIA-CHI WANG; Yang, Sheng Shun; Mo, Lein Ray; Chen, Guei Ying; Chang, Chun Chao; Wang, Szu Jen; Huang, Chia Sheng; Hsieh, Tsai Yuan; Lin, Chih Wen; Lee, Tzong Hsi; Chong, Lee Won; Huang, Chien Wei; Chang, Shiuh Nan; Tsai, Ming Chang; Hsu, Shih Jer; JIA-HORNG KAO; CHUN-JEN LIU; CHEN-HUA LIU; Lin, Han Chieh; Lee, Mei Hsuan; Tsai, Pei Chien; Dai, Chia Yen; Chuang, Wan Long; Chen, Chi Yi; Yu, Ming Lung |
| 臺大學術典藏 |
2021-12-14T23:12:15Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
CHEN-HUA LIU; Chen, Chi Yi; Su, Wei Wen; CHUN-JEN LIU; Lo, Ching Chu; Huang, Ke Jhang; Chen, Jyh Jou; Tseng, Kuo Chih; Chang, Chi Yang; Peng, Cheng Yuan; Shih, Yu Lueng; Huang, Chia Sheng; Kao, Wei Yu; Yang, Sheng Shun; Tsai, Ming Chang; Wu, Jo Hsuan; Chen, Po Yueh; Su, Pei Yuan; Hwang, Jow Jyh; Fang, Yu Jen; Lee, Pei Lun; Tseng, Chi Wei; Lee, Fu Jen; Lai, Hsueh Chou; Hsieh, Tsai Yuan; Chang, Chun Chao; Chang, Chung Hsin; Huang, Yi Jie; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-12-14T23:11:58Z |
Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate
|
Chang, Huai Lung; Wen, Wan Hsin; CHIEN-NAN LEE; Chiu, Yu En; CHUN-JEN LIU; MEI-HWEI CHANG; Lin, Lung Huang; HUEY-LING CHEN |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
CHUN-MING HONG; Lin, You Yu; CHUN-JEN LIU; Lai, Ya Yun; Shiou-Hwei Yeh; HUNG-CHIH YANG; JIA-HORNG KAO; Hsu, Shih Jer; Huang, Yi Hsiang; Yang, Sheng Shun; Kuo, Hsing Tao; Cheng, Pin Nan; Yu, Ming Lung; PEI-JER CHEN |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang, Shang Chin; Cheng, Pin Nan; CHEN-HUA LIU; HUNG-CHIH YANG; TUNG-HUNG SU; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-14T23:18:55Z |
Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV
|
CHUN-JEN LIU; PEI-JER CHEN |
| 臺大學術典藏 |
2021-09-14T23:18:54Z |
Molecular mechanisms and animal models of HBV-related hepatocellular carcinoma: With emphasis on metastatic tumor antigen 1
|
Li, Yung Tsung; Wu, Hui Lin; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-14T23:18:54Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh, Ming Lun; Hung, Chao Hung; Tseng, Kuo Chih; Lai, Hsueh Chou; Chen, Chi Yi; Kuo, Hsing Tao; Wang, Jing Houng; Chen, Jyh Jou; Lee, Pei Lun; Chien, Rong Nan; Yang, Chi Chieh; Lo, Gin Ho; Tai, Chi Ming; Lin, Chih Wen; JIA-HORNG KAO; CHEN-HUA LIU; Yan, Sheng Lei; Bair, Ming Jong; Lin, Chun Yen; Su, Wei Wen; Chu, Cheng Hsin; Chen, Chih Jen; Tung, Shui Yi; Lo, Ching Chu; Cheng, Pin Nan; Chiu, Yen Cheng; CHIA-CHI WANG; Cheng, Jin Shiung; Tsai, Wei Lun; Lin, Han Chieh; Huang, Yi Hsiang; Huang, Chung Feng; Huang, Jee Fu; Dai, Chia Yen; Chuang, Wan Long; Tsai, Pei Chien; Peng, Cheng Yuan; CHUN-JEN LIU; Yu, Ming Lung |
| 臺大學術典藏 |
2021-09-14T23:18:28Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
TUNG-HUNG SU; Peng, Cheng Yuan; Chang, Shan Han; Tseng, Tai Chung; CHUN-JEN LIU; CHI-LING CHEN; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; JIA-HORNG KAO |
Showing items 331-355 of 543 (22 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page
|
